Table of Content
Chapter 1 Executive Summary
1.1 Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018)
1.2 Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)
Chapter 2 Preface
2.1 Report description
2.2 Market Segmentation
2.3 Research Methodology
Chapter 3 Industry Analysis
3.1 Introduction
3.2 Market Drivers
3.2.1 Rapidly increasing aging population
3.2.2 Rising incidence rate of PVD
3.2.3 Increasing demand for minimally invasive endovascular procedures
3.2.4 Increase in specialists treating PVD
3.2.5 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Infections from peripheral vascular implantations
3.3.2 Strict approval process from government bodies
3.3.3 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Big opportunity in emerging economies with high unmet needs
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining power of buyers
3.5.2 Bargaining power of suppliers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis
Chapter 4 Global Peripheral Vascular Devices Market, by Segments
4.1 Overview
4.1.1 Global Peripheral Vascular Devices Market, by Product Types, 2010 – 2018 (USD Million)
4.2 Peripheral Vascular Stents
4.2.1 Global Peripheral Vascular Stents Market, by Segments, 2010 – 2018 (USD Million)
4.3 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
4.3.1 Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010 – 2018 (USD Million)
4.4 PTA Guidewires
4.4.1 Global PTA Guidewires Market, 2010 – 2018 (USD Million)
4.5 Atherectomy Devices
4.5.1 Global Atherectomy Devices Market, by Segments, 2010 – 2018 (USD Million)
4.6 Chronic Total Occlusion (CTO) Devices
4.6.1 Global Chronic Total Occlusion Devices Market, 2010 – 2018 (USD Million)
4.7 Aortic Stents
4.7.1 Global Aortic Stents Market, 2010 – 2018 (USD Million)
4.8 Synthetic Surgical Grafts
4.8.1 Global Synthetic Surgical Grafts Market, 2010 – 2018 (USD Million)
4.9 Embolic Protection Devices
4.9.1 Global Embolic Protection Devices Market, by Segments, 2010 – 2018 (USD Million)
4.10 Inferior Vena Cava Filters
4.10.1 Global Inferior Vena Cava Filters Market, by Segments, 2010 – 2018 (USD Million)
Chapter 5 Global Peripheral Vascular Devices Market, by Geography
5.1 Overview
5.1.1 Global Peripheral Vascular Devices Market, by Geography, 2010 – 2018 (USD Million)
5.2 Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)
5.3 North America
5.3.1 North America Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.3.1.1 Peripheral vascular stents
5.3.1.2 Peripheral transluminal angioplasty balloon catheters
5.3.1.3 PTA guidewires
5.3.1.4 Atherectomy devices
5.3.1.5 Chronic total occlusion devices
5.3.1.6 Aortic stents
5.3.1.7 Synthetic surgical grafts
5.3.1.8 Embolic protection devices
5.3.1.9 Inferior vena cava filters
5.4 Europe
5.4.1 Europe Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.4.1.1 Peripheral vascular stents
5.4.1.2 Peripheral transluminal angioplasty balloon catheters
5.4.1.3 PTA guidewires
5.4.1.4 Atherectomy devices
5.4.1.5 Chronic total occlusion devices
5.4.1.6 Aortic stents
5.4.1.7 Synthetic surgical grafts
5.4.1.8 Embolic protection devices
5.4.1.9 Inferior vena cava filters
5.5 Asia-Pacific
5.5.1 Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.5.1.1 Peripheral vascular stents
5.5.1.2 Peripheral transluminal angioplasty balloon catheters
5.5.1.3 PTA guidewires
5.5.1.4 Atherectomy devices
5.5.1.5 Chronic total occlusion devices
5.5.1.6 Aortic stents
5.5.1.7 Synthetic surgical grafts
5.5.1.8 Embolic protection devices
5.5.1.9 Inferior vena cava filters
5.6 RoW
5.6.1 RoW Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.6.1.1 Peripheral vascular stents
5.6.1.2 Peripheral transluminal angioplasty balloon catheters
5.6.1.3 PTA guidewires
5.6.1.4 Atherectomy devices
5.6.1.5 Chronic total occlusion devices
5.6.1.6 Aortic stents
5.6.1.7 Synthetic surgical grafts
5.6.1.8 Embolic protection devices
5.6.1.9 Inferior vena cava filters
Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players (%)
Chapter 7 Recommendations
7.1 Research and development initiatives
7.2 Investing in emerging economies
7.3 Mergers and acquisitions to expand the market presence
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product portfolio
8.1.4 Business Strategies
8.1.5 Recent developments
8.2 Angioscore Inc.
8.2.1 Company overview
8.2.2 Financial overview
8.2.3 Product portfolio
8.2.4 Business strategies
8.2.5 Recent developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product portfolio
8.3.4 Business strategies
8.3.5 Recent developments
8.4 C.R.Bard, Inc.
8.4.1 Company overview
8.4.2 Financial overview
8.4.3 Product portfolio
8.4.4 Business strategies
8.5 Cook Group Inc.
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business strategies
8.5.5 Recent developments
8.6 Cordis Corporation
8.6.1 Company overview
8.6.2 Financial overview
8.6.3 Product portfolio
8.6.4 Business strategies
8.6.5 Recent developments
8.7 Covidien PLC
8.7.1 Company overview
8.7.2 Financial overview
8.7.3 Product portfolio
8.7.4 Business strategies
8.7.5 Recent developments
8.8 Edward Lifesciences Corporation
8.8.1 Company overview
8.8.2 Financial overview
8.8.3 Product portfolio
8.8.4 Business strategies
8.8.5 Recent developments
8.9 Medtronic Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 St. Jude Medical
8.10.1 Company overview
8.10.2 Financial overview
8.10.3 Product portfolio
8.10.4 Business strategies
8.10.5 Recent developments
8.11 Volcano Corporation
8.11.1 Company overview
8.11.2 Financial overview
8.11.3 Product portfolio
8.11.4 Business strategies
8.11.5 Recent developments
List of Tables
TABLE 1 Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018)
TABLE 2 Impact Analysis of Market Drivers
TABLE 3 Impact Analysis of Market Restraints
TABLE 4 Global Peripheral Vascular Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 5 Global Peripheral Vascular Stents Market, by Segments, 2010 – 2018 (USD Million)
TABLE 6 Global Atherectomy Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 7 Global Embolic Protection Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 8 Global Inferior Vena Cava Filters Market, by Segments, 2010 – 2018 (USD Million)
TABLE 9 Global Peripheral Vascular Devices Market, by Geography, 2010 – 2018 (USD Million)
TABLE 10 North America Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 11 Europe Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 12 Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 13 RoW Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
List of Figures
FIG. 1 Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)
FIG. 2 Peripheral Vascular Devices: Market Segmentation
FIG. 3 Porter’s Five Forces Analysis: Global Peripheral Vascular Devices Market
FIG. 4 Market Attractiveness Analysis: Global Peripheral Vascular Devices Market, by Geography
FIG. 5 Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010 – 2018 (USD Million)
FIG. 6 Global PTA Guidewires Market, 2010 – 2018 (USD Million)
FIG. 7 Global Chronic Total Occlusion Devices Market, 2010 – 2018 (USD Million)
FIG. 8 Global Aortic Stents Market, 2010 – 2018 (USD Million)
FIG. 9 Global Synthetic Surgical Grafts Market, 2010 – 2018 (USD Million)
FIG. 10 Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)
FIG. 11 Peripheral Vascular Devices: Market Share, by Key Players, 2012 (%)
FIG. 13 Net Sales: Boston Scientific Corporation, 2010 – 2012 (USD Billion)
FIG. 14 Net Sales: C.R.Bard, Inc., 2010 – 2012 (USD Billion)
FIG. 15 Net Sales: Covidien Plc, 2010 – 2012 (USD Billion)
FIG. 16 Net Sales: Edward Lifesciences Corporation, 2010 – 2012 (USD Billion)
FIG. 17 Net Sales: Medtronic Inc., 2010 – 2012 (USD Billion)
FIG. 18 Net Sales: St. Jude Medical, Inc., 2010 – 2012 (USD Billion)
FIG. 19 Net Sales: Volcano Corporation, 2010 – 2012 (USD Million)